RxDoctor Payments Data

Marilyn Sorensen

Nurse Practitioner · Payson, UTNPI 1568480713

Payments from drug & device makers

$547in general payments, 2019–2025

Across 28 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$108
  • AbbVie$80
  • Novo Nordisk$50
  • Lilly USA, LLC$46
  • Organon$37
  • Amgen$25
  • plus $201 from 13 others

What the payments were for

  • Food & beverage$547100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$547 in reported general payments places this provider in the 70th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$15,266
Medicare patients
55
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProgesteroneProgesterone, Micronized226$12,819
MounjaroTirzepatide12$12,191
Liothyronine Sodium118$4,949
Estradiol (Twice Weekly)Estradiol37$4,872
DottiEstradiol27$2,410
Levothyroxine Sodium102$1,139
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$654
Testosterone Cypionate22$530
Gabapentin31$463
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$444
Lisinopril32$413
Metformin Hcl ErMetformin Hcl26$385
Losartan Potassium23$374
Atorvastatin Calcium25$362
Omeprazole16$356

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$46$12,19112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Payson

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →